lysophosphatidylethanolamine (20:4(8Z,11Z,14Z,17Z)/0:0)

Term ID

CHEBI:72742

Synonyms

(2R)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
LPE 20:4(8Z,11Z,14Z,17Z)/0:0
LPE(20:4(8Z,11Z,14Z,17Z)/0:0)
Lyso-PE(20:4(8Z,11Z,14Z,17Z)/0:0)
LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0)
PE 20:4(8Z,11Z,14Z,17Z)/0:0
PE(20:4(8Z,11Z,14Z,17Z)/0:0)

Definition

A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 8Z,11Z,14Z,17Z-eicosapentaenoyl (omega-3-arachidonoyl).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 20:4

1-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 20:4 Show first 5 Terms
has_functional_parent: all-cis-8,11,14,17-icosatetraenoic acid

all-cis-8,11,14,17-icosatetraenoic acid Show first 5 Terms
has_role: metabolite

metabolite Show first 5 Terms

Phenotype

Phenotype resulting from lysophosphatidylethanolamine (20:4(8Z,11Z,14Z,17Z)/0:0)

Phenotype where environments contain lysophosphatidylethanolamine (20:4(8Z,11Z,14Z,17Z)/0:0)

Phenotype modified by environments containing lysophosphatidylethanolamine (20:4(8Z,11Z,14Z,17Z)/0:0)

Human Disease Model